Replimune Group, Inc. (REPL)
8.85
+0.38
(+4.49%)
USD |
NASDAQ |
Jun 11, 14:46
Replimune Group Accounts Payable (Quarterly) : 5.647M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 5.647M |
| September 30, 2025 | 6.404M |
| June 30, 2025 | 15.48M |
| March 31, 2025 | 12.46M |
| December 31, 2024 | 7.188M |
| September 30, 2024 | 8.41M |
| June 30, 2024 | 0.864M |
| March 31, 2024 | 2.578M |
| December 31, 2023 | 3.903M |
| September 30, 2023 | 4.365M |
| June 30, 2023 | 4.883M |
| March 31, 2023 | 5.364M |
| December 31, 2022 | 3.648M |
| September 30, 2022 | 3.996M |
| June 30, 2022 | 4.482M |
| March 31, 2022 | 3.732M |
| December 31, 2021 | 3.922M |
| September 30, 2021 | 3.154M |
| Date | Value |
|---|---|
| June 30, 2021 | 2.382M |
| March 31, 2021 | 2.355M |
| December 31, 2020 | 2.35M |
| September 30, 2020 | 2.374M |
| June 30, 2020 | 3.48M |
| March 31, 2020 | 3.434M |
| December 31, 2019 | 6.256M |
| September 30, 2019 | 7.965M |
| June 30, 2019 | 10.83M |
| March 31, 2019 | 7.084M |
| December 31, 2018 | 1.501M |
| September 30, 2018 | 2.072M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 1.993M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 0.323M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 80.54M |
| Oncolytics Biotech, Inc. | 0.00 |
| Rocket Pharmaceuticals, Inc. | 0.00 |
| Cogent Biosciences, Inc. | 13.74M |
| Lantern Pharma, Inc. | 3.718M |